Establishment of a novel mouse model of ulcerative colitis with concomitant cytomegalovirus infection: In vivo identification of cytomegalovirus persistent infected cells

Inflammatory Bowel Diseases

Volumn 19, Issue 9, 2013, Pages 1951-1963

  Matsumura, Kayoko ^a   Nakase, Hiroshi ^a   Kosugi, Isao ^b   Honzawa, Yusuke ^a   Yoshino, Takuya ^a   Matsuura, Minoru ^a   Kawasaki, Hideya ^b   Arai, Yoshifumi ^b   Iwashita, Toshihide ^b   Nagasawa, Takashi ^c   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cytomegalovirus; Perivascular cells; Ulcerative colitis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKINE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS; VIRUS IDENTIFICATION;

ANIMALS; COLITIS, ULCERATIVE; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84884628142     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318293c5bf     Document Type: Article

References (50)

1. McGavran MH, Smith MG. Ultrastructural cytochemical and microchemical observations on cytomegalovirus (salivary gland virus) infection of human cells in tissue culture. Exp Mol Pathol. 1965;76:1-10.
2. Pass RF. Epidemiology and transmission of cytomegalovirus. J Infect Dis. 1985;152:243-248.
3. Nakase H, Matsumura K, Yoshino T, et al. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2008; 43:735-740.
4. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, et al. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum. 1999; 42:24-30.
5. Kuwabara A, Okamoto H, Suda T, et al. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007;42:823-829.
6. Nakase H, Yoshino T, Honzawa Y, et al. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci. 2010;55:1498-1499.
7. Simon CO, Seckert CK, Dreis D, et al. Role of tumor necrosis factor-a in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol. 2005;79:326-340.
8. Onyeagocha C, Hossain MS, Kumar A, et al. Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol. 2009;175:2034-2042.
9. Messerle M, Keil GM, Schneider K, et al. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. Virology. 1992;191:355-367.
10. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993; 75:275-282.
11. Mizoguchi A, Mizoguchi E, Chiba C, et al. Cytokine imbalance and autoantibody production in T cell receptor-mutant mice with inflammatory bowel disease. J Exp Med. 1996;183:847-856.
12. Arai Y, Ishiwata M, Baba S, et al. Neuron-specific activation of murine cytomegalovirus early gene e1 promoter in transgenic mice. Am J Pathol. 1993;163:643-652.
13. Yamada S, Kosugi I, Katano H, et al. In vivo imaging assay for the convenient evaluation of antiviral compounds against cytomegalovirus in mice. Antiviral Res. 2010;88:45-52.
14. Tang Q, Bell P, Tegtmeyer P, et al. Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J Virol. 2000; 74:9694-9700.
15. Okuda Y, Takahashi I, Kim JK. Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor alpha-deficient mice: a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ betabeta T cells. Am J Pathol. 2003;162:263-271.
16. Inoue S, Nakase H, Matsuura M, et al. The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease. Clin Exp Immunol. 2009;156:172-182.
17. Kosugi I, Kawasaki H, Arai Y, et al. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am J Pathol. 2002;161:919-928.
18. Kosugi I, Shinmura Y, Li RY, et al. Murine cytomegalovirus induces apoptosis in non-infected cells of the developing mouse brain and blocks apoptosis in primary neuronal culture. Acta Neuropathol. 1998;96:239-247.
19. Lembo D, Brune W. Tinkering with a viral ribonucleotide reductase. Trends Biochem Sci. 2009;34:25-32.
20. Wagner M, Jonjic S, Koszinowski UH, et al. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol. 1999;73:7056-7060.
21. Prinz I, Klemm U, Kaufmann SH, et al. Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCR alpha chain transgenic mice. Gastroenterology. 2004;126:170-181.
22. Walton SM, Wyrsch P, Munks MW, et al. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol. 2008;181:1128-1134.
23. Chan G, Bivins-Smith ER, Smith MS, et al. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol. 2008;181:698-711.
24. Nehls V, Drenckhahn D. The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry. 1993;99:1-12.
25. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193-215.
26. Lindahl P, Johansson BR, Levéen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242-245.
27. Hellström M, Kalén M, Lindahl P, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047-3055.
28. Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977-988.
29. Mikami S, Nakase H, Yamamoto S, et al. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis. J Pharmacol Exp Ther. 2008;327:383-392.
30. Berk T, Gordon SJ, Choi HY, et al. Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol. 1985;80:355-360.
31. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16:1620-1627.
32. Cardin RD, Abenes GB, Stoddart CA, et al. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology. 1995;209:236-241.
33. Yoshino T, Nakase H, Ueno S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis. 2007;13:1516-1521.
34. Munks MW, Cho KS, Pinto AK, et al. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol. 2006;177:450-458.
35. Mutnal MB, Hu S, Little MR, et al. Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-g. J Neurovirol. 2011;17:424-437.
36. Helanterä I, Loginov R, Koskinen P. Persistent cytomegalovirus infection is associated with increased expression of TGF-b1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrol Dial Transplant. 2005;20:790-796.
37. Dilloo D, Josting A, Burdach S. CMV infection modulates interleukin-6 production in human bone marrow stroma cells. Bone Marrow Transplant. 1991;7:152.
38. Rahbar A, Boström L, Lagerstedt U, et al. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2003;9:154-161.
39. Parekh T, Saxena B, Reibman J, et al. Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin. J Immunol. 1994;152:2456-2466.
40. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958-969.
41. Grundy JE, Lawson KM, MacCormac LP, et al. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis. 1998; 177:1465-1474.
42. Foucar E, Mukai K, Foucar K, et al. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol. 1981;76:788-801.
43. Sinzger C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol. 1995; 76:741-750.
44. Kambham N, Vij R, Cartwright CA, et al. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004;28:365-373.
45. Al-Zafiri R, Gologan A, Galiatsatos P, et al. Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a communitybased, university-affiliated hospital. Gastroenterol Hepatol. 2012;8: 230-239.
46. Eyre-Brook IA, Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut. 1986;27:1419-1425.
47. Reinhardt B, Mertens T, Mayr-Beyrle U, et al. HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res. 2005;67:151-160.
48. Siegbahn A, Hammacher A, Westermark B, et al. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest. 1990;85: 916-920.
49. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283-1316.
50. Delano MJ, Kelly-Scumpia KM, Thayer TC. Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. J Immunol. 2011;187:911-918.